SNN vs. BSX

In the year-to-date period, SNN achieves a -3.66% return, which is significantly lower than BSX's 56.46% return. Over the past 10 years, SNN has underperformed BSX with an annualized return of -0.86%, while BSX has yielded a comparatively higher 21.53% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Smith & Nephew plc (SNN) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current SNN Sharpe Ratio is 0.11, which is lower than the BSX Sharpe Ratio of 3.92. The chart below compares the historical Sharpe Ratios of SNN and BSX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

SNN's dividend yield for the trailing twelve months is around 2.94%, while BSX has not paid dividends to shareholders.

The maximum SNN drawdown since its inception was -55.20%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for SNN and BSX. For additional features, visit the drawdowns tool.

Smith & Nephew plc (SNN) has a higher volatility of 15.88% compared to Boston Scientific Corporation (BSX) at 5.84%. This indicates that SNN's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Smith & Nephew plc and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.